Avi Kremer, Prize4Life Co-Founder and CEO, Wins Israeli Prime Minister’s Prize for Initiative and Innovation

Share Article

Israeli Prime Minister Benjamin Netanyahu awarded Prize4Life CEO Avi Kremer with the Prime Minister's Prize for Initiative and Innovation for his efforts to accelerate the discovery of treatments and a cure for ALS through the use of the incentive prize model.

Prize4Life

“I am flattered and humbled to receive this prize,” said [Prize4Life CEO] Avi Kremer, “The decision of the distinguished national committee is a testament to the innovation and impact of the Prize4Life model."

Prize4Life, a non-profit organization dedicated to achieving breakthroughs in effective treatments for Amyotrophic Lateral Sclerosis (ALS), is pleased to announce that Avi Kremer, co-founder and Chief Executive Officer of Prize4Life, will be awarded the “Prime Minister’s Prize for Initiatives and Innovations Not for Profit” by Israeli Prime Minister Benjamin Netanyahu.

The Prizes are designed to encourage and promote innovative and creative thinking in business ventures that have the potential to inspire significant changes in science, technology and society. “I am flattered and humbled to receive this prize,” said Avi Kremer, “The decision of the distinguished national committee is a testament to the innovation and impact of the Prize4Life model—an efficient and results-oriented model that has already proven its worth in helping to advance ALS research. This prize belongs to the thousands of people who have supported Prize4Life since its founding as much as it belongs to me.”

Kremer founded Prize4Life in 2007 shortly after he was diagnosed with ALS and will be recognized for his groundbreaking strategy to use incentive prizes to further medical research for which conventional funding and development methods are not sufficient. Prize4Life’s incentive model had its first major success in February of this year when the organization awarded the $1 million ALS Biomarker Prize for a technology that is now used in ALS related clinical trials to measure disease progression. The ALS Biomarker Prize is the first of its kind to bridge the gap between ALS research and breakthroughs that can benefit patients by making clinical trials cheaper, faster, and more appealing to investment from industry. Kremer’s model continues to direct new minds and resources toward the effort to find viable treatments or a cure for ALS while providing a source of hope for ALS patients and their families.

The Prime Minister’s Prizes will be awarded for the second time in history during a ceremony at The Hebrew University in Jerusalem, Israel on November 15, 2011 as part of Israel’s participation in Global Entrepreneurship Week. More than one hundred countries will take part in the roundtable conferences and collaborative sessions highlighting entrepreneurship worldwide from November 14-20, 2011.

About Prize4Life

Prize4Life is a nonprofit organization dedicated to accelerating the discovery of treatments and a cure for ALS by using powerful incentives to attract new people and drive innovation. Prize4Life was founded in 2006 by Avi Kremer, who was diagnosed with ALS at the age of 29 while attending Harvard Business School. The organization aims to use prizes to bring new minds and new money into the fight against ALS and focus efforts on specific outcomes that will bridge the gap between academic research and the development of treatments and a cure.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sarah Groothuis
Visit website